{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:26:25Z","timestamp":1792463185559,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012331","name":"LEO Fondet","doi-asserted-by":"publisher","award":["LF18002"],"award-info":[{"award-number":["LF18002"]}],"id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s40257-022-00707-x","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T02:03:18Z","timestamp":1656640998000},"page":"635-646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Treatment of Hyperhidrosis: An Update"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1991-2248","authenticated-orcid":false,"given":"Mattias A. S.","family":"Henning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8969-7144","authenticated-orcid":false,"given":"Dorra","family":"Bouazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0712-2540","authenticated-orcid":false,"given":"Gregor B. E.","family":"Jemec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"issue":"2","key":"707_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaad.2003.12.029","volume":"51","author":"J Hornberger","year":"2004","unstructured":"Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51(2):274\u201386.","journal-title":"J Am Acad Dermatol"},{"issue":"24","key":"707_CR2","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1097\/00029330-200712020-00011","volume":"120","author":"X Li","year":"2007","unstructured":"Li X, Chen R, Tu YR, Lin M, Lai FC, Li YP, et al. Epidemiological survey of primary palmar hyperhidrosis in adolescents. Chin Med J (Engl). 2007;120(24):2215\u20137.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"707_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ejcts.2007.01.020","volume":"31","author":"YR Tu","year":"2007","unstructured":"Tu YR, Li X, Lin M, Lai FC, Li YP, Chen JF, et al. Epidemiological survey of primary palmar hyperhidrosis in adolescent in Fuzhou of People\u2019s Republic of China. Eur J Cardiothorac Surg. 2007;31(4):737\u20139.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"707_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092412","volume":"9","author":"KM Gross","year":"2014","unstructured":"Gross KM, Schote AB, Schneider KK, Schulz A, Meyer J. Elevated social stress levels and depressive symptoms in primary hyperhidrosis. PLoS\u00a0One. 2014;9(3): e92412.","journal-title":"PLoS\u00a0One"},{"key":"707_CR5","doi-asserted-by":"crossref","unstructured":"Henning MAS, Ibler KS, Loft I, Ostrowski SR, Erikstrup C, Nielsen KR, et al. The health-related quality of life in hyperhidrosis and co-morbidities. Qual Life Res; 2022.","DOI":"10.1007\/s11136-022-03108-z"},{"issue":"1","key":"707_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.det.2015.07.003","volume":"34","author":"IE Deckers","year":"2016","unstructured":"Deckers IE, Kimball AB. The handicap of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):17\u201322.","journal-title":"Dermatol Clin"},{"key":"707_CR7","unstructured":"Kristensen JK, Grejsen D, Swartling C, Bygum A. In hyperhidrosis quality of life is even worse than in acne, eczema, or psoriasis. A comparison of Skindex-16 and Dermatology Life Quality Index (DLQI). Int J Dermatol. 2020."},{"issue":"6","key":"707_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000486713","volume":"233","author":"A Shayesteh","year":"2017","unstructured":"Shayesteh A, Janlert U, Nylander E. Hyperhidrosis\u2014sweating sites matter: quality of life in primary hyperhidrosis according to the sweating sites measured by SF-36. Dermatology. 2017;233(6):441\u20135.","journal-title":"Dermatology"},{"key":"707_CR9","unstructured":"Henning MAS, Ibler KS, Ostrowski SR, Erikstrup C, Nielsen KR, Bruun MT, et al. Hyperhidrosis and the risk of being treated for skin infections. J Dermatol Treat. 2021:1\u20137."},{"issue":"4","key":"707_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/01.pra.0000452570.69578.31","volume":"20","author":"R Lessa Lda","year":"2014","unstructured":"Lessa Lda R, Luz FB, De Rezende RM, Duraes SM, Harrison BJ, De Menezes GB, et al. The psychiatric facet of hyperhidrosis: demographics, disability, quality of life, and associated psychopathology. J Psychiatr Pract. 2014;20(4):316\u201323.","journal-title":"J Psychiatr Pract"},{"issue":"6","key":"707_CR11","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jaad.2016.07.001","volume":"75","author":"R Bahar","year":"2016","unstructured":"Bahar R, Zhou P, Liu Y, Huang Y, Phillips A, Lee TK, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol. 2016;75(6):1126\u201333.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"707_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jaad.2009.02.038","volume":"61","author":"HW Walling","year":"2009","unstructured":"Walling HW. Primary hyperhidrosis increases the risk of cutaneous infection: a case\u2013control study of 387 patients. J Am Acad Dermatol. 2009;61(2):242\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"707_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00403-016-1697-9","volume":"308","author":"J Doolittle","year":"2016","unstructured":"Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016;308(10):743\u20139.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"707_CR14","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s00266-021-02140-7","volume":"45","author":"D Obed","year":"2021","unstructured":"Obed D, Salim M, Bingoel AS, Hofmann TR, Vogt PM, Krezdorn N. Botulinum toxin versus placebo: a meta-analysis of treatment and quality-of-life outcomes for hyperhidrosis. Aesthetic Plast Surg. 2021;45(4):1783\u201391.","journal-title":"Aesthetic Plast Surg"},{"issue":"9","key":"707_CR15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/lsm.23229","volume":"52","author":"C Parrish","year":"2020","unstructured":"Parrish C, Waldbaum B, Coleman D, Blevins C, Rodgers K, Lee B, et al. Microwave thermolysis reduces generalized and social anxiety in young adults with axillary hyperhidrosis. Lasers Surg Med. 2020;52(9):842\u20137.","journal-title":"Lasers Surg Med"},{"issue":"6","key":"707_CR16","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/bjd.15808","volume":"178","author":"Y Hu","year":"2018","unstructured":"Hu Y, Converse C, Lyons MC, Hsu WH. Neural control of sweat secretion: a review. Br J Dermatol. 2018;178(6):1246\u201356.","journal-title":"Br J Dermatol"},{"issue":"3","key":"707_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/bjd.16558","volume":"179","author":"R Wade","year":"2018","unstructured":"Wade R, Llewellyn A, Jones-Diette J, Wright K, Rice S, Layton AM, et al. Interventional management of hyperhidrosis in secondary care: a systematic review. Br J Dermatol. 2018;179(3):599\u2013608.","journal-title":"Br J Dermatol"},{"issue":"1","key":"707_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40257-018-0395-0","volume":"20","author":"DM Pariser","year":"2019","unstructured":"Pariser DM, Hebert AA, Drew J, Quiring J, Gopalan R, Glaser DA. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: patient-reported outcomes from the ATMOS-1 and ATMOS-2 Phase III randomized controlled trials. Am J Clin Dermatol. 2019;20(1):135\u201345.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"707_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaad.2018.07.002","volume":"80","author":"DA Glaser","year":"2019","unstructured":"Glaser DA, Hebert AA, Nast A, Werschler WP, Green L, Mamelok R, et al. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials. J Am Acad Dermatol. 2019;80(1):128-38.e2.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"707_CR20","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/1346-8138.15927","volume":"48","author":"T Fujimoto","year":"2021","unstructured":"Fujimoto T, Abe Y, Igarashi M, Ishikoh A, Omi T, Kanda H, et al. A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis. J Dermatol. 2021;48(8):1149\u201361.","journal-title":"J Dermatol"},{"key":"707_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2147\/CCID.S210973","volume":"12","author":"S Gregoriou","year":"2019","unstructured":"Gregoriou S, Sidiropoulou P, Kontochristopoulos G, Rigopoulos D. Management strategies of palmar hyperhidrosis: challenges and solutions. Clin Cosmet Investig Dermatol. 2019;12:733\u201344.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"707_CR22","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/DSS.0000000000001532","volume":"44","author":"S Lueangarun","year":"2018","unstructured":"Lueangarun S, Sermsilp C, Tempark T. Topical botulinum toxin type A liposomal cream for primary axillary hyperhidrosis: a double-blind, randomized, split-site, vehicle-controlled study. Dermatol Surg. 2018;44(8):1094\u2013101.","journal-title":"Dermatol Surg"},{"issue":"2","key":"707_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1524-4725.2011.02250.x","volume":"38","author":"DA Glaser","year":"2012","unstructured":"Glaser DA, Coleman WP 3rd, Fan LK, Kaminer MS, Kilmer SL, Nossa R, et al. A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study. Dermatol Surg. 2012;38(2):185\u201391.","journal-title":"Dermatol Surg"},{"issue":"2","key":"707_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/lsm.22324","volume":"47","author":"FM Lecl\u00e8re","year":"2015","unstructured":"Lecl\u00e8re FM, Moreno-Moraga J, Alcolea JM, Vogt PM, Royo J, Cornejo P, et al. Efficacy and safety of laser therapy on axillary hyperhidrosis after one year follow-up: a randomized blinded controlled trial. Lasers Surg Med. 2015;47(2):173\u20139.","journal-title":"Lasers Surg Med"},{"issue":"1","key":"707_CR25","first-page":"59","volume":"11","author":"PR Letada","year":"2012","unstructured":"Letada PR, Landers JT, Uebelhoer NS, Shumaker PR. Treatment of focal axillary hyperhidrosis using a long-pulsed Nd:YAG 1064 nm laser at hair reduction settings. J Drugs Dermatol. 2012;11(1):59\u201363.","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"707_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/ajd.12260","volume":"56","author":"F Fatemi Naeini","year":"2015","unstructured":"Fatemi Naeini F, Abtahi-Naeini B, Pourazizi M, Nilforoushzadeh MA, Mirmohammadkhani M. Fractionated microneedle radiofrequency for treatment of primary axillary hyperhidrosis: a sham control study. Australas J Dermatol. 2015;56(4):279\u201384.","journal-title":"Australas J Dermatol"},{"issue":"Suppl 1","key":"707_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2133.2011.10786.x","volume":"166","author":"DF Swaile","year":"2012","unstructured":"Swaile DF, Elstun LT, Benzing KW. Clinical studies of sweat rate reduction by an over-the-counter soft-solid antiperspirant and comparison with a prescription antiperspirant product in male panelists. Br J Dermatol. 2012;166(Suppl 1):22\u20136.","journal-title":"Br J Dermatol"},{"issue":"6","key":"707_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14354","volume":"33","author":"T Thianboonsong","year":"2020","unstructured":"Thianboonsong T, Kanokrungsee S, Paichitrojjana A, Udompataikul M, Kamanamool N, Rojhirunsakool S. Efficacy and tolerability of 20% aluminum sesquichlorohydrate vs 20% aluminum chloride for the treatment of axillary hyperhidrosis: a randomized controlled trial. Dermatol Ther. 2020;33(6): e14354.","journal-title":"Dermatol Ther"},{"issue":"2","key":"707_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00105-009-1841-y","volume":"61","author":"M Streker","year":"2010","unstructured":"Streker M, Reuther T, Verst S, Kerscher M. Axillary hyperhidrosis\u2013efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis. Hautarzt. 2010;61(2):139\u201344.","journal-title":"Hautarzt"},{"issue":"5","key":"707_CR30","first-page":"477","volume":"8","author":"KH Flanagan","year":"2009","unstructured":"Flanagan KH, Glaser DA. An open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis. J Drugs Dermatol. 2009;8(5):477\u201380.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"707_CR31","first-page":"115","volume":"10","author":"M Streker","year":"2012","unstructured":"Streker M, Reuther T, Hagen L, Kerscher M. Hyperhidrosis plantaris\u2014a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminium chloride. J Dtsch Dermatol Ges. 2012;10(2):115\u20139.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"707_CR32","first-page":"229","volume":"182","author":"C Masur","year":"2020","unstructured":"Masur C, Soeberdt M, Kilic A, Knie U, Abels C. Safety and efficacy of topical formulations containing 0\u00b75, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double-blind, placebo-controlled study. Br J Dermatol. 2020;182(1):229\u201331.","journal-title":"Br J Dermatol"},{"issue":"2","key":"707_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bjd.19810","volume":"185","author":"C Abels","year":"2021","unstructured":"Abels C, Soeberdt M, Kilic A, Reich H, Knie U, Jourdan C, et al. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. Br J Dermatol. 2021;185(2):315\u201322.","journal-title":"Br J Dermatol"},{"issue":"2","key":"707_CR34","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/jdv.12518","volume":"29","author":"MY Hyun","year":"2015","unstructured":"Hyun MY, Son IP, Lee Y, Choi HG, Park KY, Li K, et al. Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double-blinded, placebo-controlled, split-face study. J Eur Acad Dermatol Venereol. 2015;29(2):278\u201382.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"707_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/pde.13723","volume":"36","author":"AA Hebert","year":"2019","unstructured":"Hebert AA, Glaser DA, Green L, Werschler WP, Forsha DW, Drew J, et al. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials. Pediatr Dermatol. 2019;36(1):89\u201399.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"707_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40257-019-00446-6","volume":"20","author":"DA Glaser","year":"2019","unstructured":"Glaser DA, Hebert AA, Nast A, Werschler WP, Green L, Mamelok RD, et al. A 44-week open-label study evaluating safety and efficacy of topical glycopyrronium tosylate in patients with primary axillary hyperhidrosis. Am J Clin Dermatol. 2019;20(4):593\u2013604.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"707_CR37","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/pde.14135","volume":"37","author":"AA Hebert","year":"2020","unstructured":"Hebert AA, Glaser DA, Green L, Hull C, Cather J, Drew J, et al. Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: post hoc pediatric subgroup analysis from a 44-week open-label extension study. Pediatr Dermatol. 2020;37(3):490\u20137.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"707_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/1346-8138.16188","volume":"49","author":"H Yokozeki","year":"2022","unstructured":"Yokozeki H, Fujimoto T, Wanatabe S, Ogawa S, Fujii C. Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: a randomized, double-blind, vehicle-controlled study. J Dermatol. 2022;49(1):86\u201394.","journal-title":"J Dermatol"},{"issue":"6","key":"707_CR39","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jaad.2020.02.016","volume":"82","author":"B Kirsch","year":"2020","unstructured":"Kirsch B, Smith S, Cohen J, DuBois J, Green L, Baumann L, et al. Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: a phase II, randomized, controlled, double-blinded trial. J Am Acad Dermatol. 2020;82(6):1321\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"707_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/1346-8138.15668","volume":"48","author":"H Yokozeki","year":"2021","unstructured":"Yokozeki H, Fujimoto T, Abe Y, Igarashi M, Ishikoh A, Omi T, et al. A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis. J Dermatol. 2021;48(3):279\u201388.","journal-title":"J Dermatol"},{"issue":"9","key":"707_CR41","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.2340\/00015555-2731","volume":"97","author":"O Artzi","year":"2017","unstructured":"Artzi O, Loizides C, Zur E, Sprecher E. Topical oxybutynin 10% gel for the treatment of primary focal hyperhidrosis: a randomized double-blind placebo-controlled split area study. Acta Derm Venereol. 2017;97(9):1120\u20134.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"707_CR42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/1346-8138.13748","volume":"44","author":"JF Mill\u00e1n-Cayetano","year":"2017","unstructured":"Mill\u00e1n-Cayetano JF, Del Boz J, Toledo-Pastrana T, Nieto-Guindo M, Garc\u00eda-Montero P, de Troya-Mart\u00edn M. Initial study of transdermal oxybutynin for treating hyperhidrosis. J Dermatol. 2017;44(6):717\u201320.","journal-title":"J Dermatol"},{"issue":"7","key":"707_CR43","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1080\/09546634.2019.1569751","volume":"30","author":"CE Gollins","year":"2019","unstructured":"Gollins CE, Carpenter A, Steen C, Bulinski H, Mahendran R. A retrospective analysis of the use of tap water iontophoresis for focal hyperhidrosis at a district general hospital: the patients\u2019 perspective. J Dermatolog Treat. 2019;30(7):724\u20136.","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"707_CR44","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/dsu.12099","volume":"39","author":"YH Choi","year":"2013","unstructured":"Choi YH, Lee SJ, Kim DW, Lee WJ, Na GY. Open clinical trial for evaluation of efficacy and safety of a portable \u201cdry-type\u201d iontophoretic device in treatment of palmar hyperhidrosis. Dermatol Surg. 2013;39(4):578\u201383.","journal-title":"Dermatol Surg"},{"issue":"4","key":"707_CR45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1440-0960.2004.00098.x","volume":"45","author":"C Dolianitis","year":"2004","unstructured":"Dolianitis C, Scarff CE, Kelly J, Sinclair R. Iontophoresis with glycopyrrolate for the treatment of palmoplantar hyperhidrosis. Australas J Dermatol. 2004;45(4):208\u201312.","journal-title":"Australas J Dermatol"},{"issue":"6","key":"707_CR46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1346-8138.2003.tb00414.x","volume":"30","author":"H Shimizu","year":"2003","unstructured":"Shimizu H, Tamada Y, Shimizu J, Ohshima Y, Matsumoto Y, Sugenoya J. Effectiveness of iontophoresis with alternating current (AC) in the treatment of patients with palmoplantar hyperhidrosis. J Dermatol. 2003;30(6):444\u20139.","journal-title":"J Dermatol"},{"issue":"3","key":"707_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.mjafi.2014.01.008","volume":"70","author":"R Rajagopal","year":"2014","unstructured":"Rajagopal R, Mallya NB. Comparative evaluation of botulinum toxin versus iontophoresis with topical aluminium chloride hexahydrate in treatment of palmar hyperhidrosis. Med J Armed Forces India. 2014;70(3):247\u201352.","journal-title":"Med J Armed Forces India"},{"issue":"4","key":"707_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/09546634.2012.739679","volume":"25","author":"L Montaser-Kouhsari","year":"2014","unstructured":"Montaser-Kouhsari L, Zartab H, Fanian F, Noorian N, Sadr B, Nassiri-Kashani M, et al. Comparison of intradermal injection with iontophoresis of abobotulinum toxin A for the treatment of primary axillary hyperhidrosis: a randomized, controlled trial. J Dermatolog Treat. 2014;25(4):337\u201341.","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"707_CR49","first-page":"501","volume":"26","author":"K Wachal","year":"2009","unstructured":"Wachal K, Bu\u0107ko W, Staniszewski R, Majewska N, B\u0142aszak M. Original paperEstimating the subjective efficiency after treatment of upper extremity hyperhidrosis using various methods. Adv Dermatol Allergol Post\u0119py Dermatol Alergol. 2009;26(6):501\u20135.","journal-title":"Adv Dermatol Allergol Post\u0119py Dermatol Alergol"},{"issue":"9","key":"707_CR50","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1468-3083.2011.04197.x","volume":"26","author":"HY Chia","year":"2012","unstructured":"Chia HY, Tan AS, Chong WS, Tey HL. Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis. J Eur Acad Dermatol Venereol. 2012;26(9):1167\u201370.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"707_CR51","first-page":"908","volume":"33","author":"N Solish","year":"2007","unstructured":"Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C, Lupin M, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg. 2007;33(8):908\u201323.","journal-title":"Dermatol Surg"},{"issue":"5","key":"707_CR52","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/pde.12620","volume":"32","author":"DA Glaser","year":"2015","unstructured":"Glaser DA, Pariser DM, Hebert AA, Landells I, Somogyi C, Weng E, et al. A prospective, nonrandomized, open-label study of the efficacy and safety of OnabotulinumtoxinA in adolescents with primary axillary hyperhidrosis. Pediatr Dermatol. 2015;32(5):609\u201317.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"707_CR53","first-page":"221","volume":"7","author":"KH Flanagan","year":"2008","unstructured":"Flanagan KH, King R, Glaser DA. Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis. J Drugs Dermatol. 2008;7(3):221\u20137.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"707_CR54","first-page":"497","volume":"306","author":"M Basciani","year":"2014","unstructured":"Basciani M, Di Rienzo F, Bizzarrini M, Zanchi M, Copetti M, Intiso D. Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study. Arch Dermatol Res. 2014;306(5):497\u2013503.","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"707_CR55","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/1346-8138.15029","volume":"46","author":"P Cabreus","year":"2019","unstructured":"Cabreus P, Swartling C, Rystedt A. Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B. J Dermatol. 2019;46(10):874\u20138.","journal-title":"J Dermatol"},{"issue":"5","key":"707_CR56","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1524-4725.2009.01140.x","volume":"35","author":"WO Kim","year":"2009","unstructured":"Kim WO, Kil HK, Yoon KB, Noh KU. Botulinum toxin: a treatment for compensatory hyperhidrosis in the trunk. Dermatol Surg. 2009;35(5):833\u20138 (discussion 8).","journal-title":"Dermatol Surg"},{"issue":"2","key":"707_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.athoracsur.2004.02.087","volume":"78","author":"PB Licht","year":"2004","unstructured":"Licht PB, Pilegaard HK. Severity of compensatory sweating after thoracoscopic sympathectomy. Ann Thorac Surg. 2004;78(2):427\u201331.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"707_CR58","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jocd.12049","volume":"12","author":"JA Adefusika","year":"2013","unstructured":"Adefusika JA, Brewer JD. OnabotulinumtoxinA therapy for compensatory hyperhidrosis. J Cosmet Dermatol. 2013;12(3):232\u20134.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"707_CR59","first-page":"68","volume":"71","author":"EE Belin","year":"2003","unstructured":"Belin EE, Polo J. Treatment of compensatory hyperhidrosis with botulinum toxin type A. Cutis. 2003;71(1):68\u201370.","journal-title":"Cutis"},{"issue":"6","key":"707_CR60","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.ejcts.2008.03.033","volume":"33","author":"CA Efthymiou","year":"2008","unstructured":"Efthymiou CA, Thorpe JA. Compensatory hyperhidrosis: a consequence of truncal sympathectomy treated by video assisted application of botulinum toxin and reoperation. Eur J Cardiothorac Surg. 2008;33(6):1157\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"707_CR61","first-page":"745","volume":"32","author":"FG Bechara","year":"2006","unstructured":"Bechara FG, Sand M, Moussa G, Sand D, Altmeyer P, Hoffmann K, et al. Treatment of unilateral compensatory sweating after endoscopical thoracic sympathectomy for general hyperhidrosis with botulinum toxin A. Dermatol Surg. 2006;32(5):745\u20138.","journal-title":"Dermatol Surg"},{"issue":"Suppl 1","key":"707_CR62","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1097\/01.DSS.0000452649.99141.69","volume":"41","author":"D Hexsel","year":"2015","unstructured":"Hexsel D, Soirefmann M, Porto MD, Schilling-Souza J, Siega C. Fields of anhidrotic effects of abobotulinumtoxinA in patients with compensatory hyperhidrosis. Dermatol Surg. 2015;41(Suppl 1):S93-100.","journal-title":"Dermatol Surg"},{"issue":"1","key":"707_CR63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10103-020-03064-5","volume":"36","author":"N Junsuwan","year":"2021","unstructured":"Junsuwan N, Manuskiatti W, Phothong W, Wanitphakdeedecha R. Fractional CO(2) laser-assisted Botulinum toxin type A delivery for the treatment of primary palmar hyperhidrosis. Lasers Med Sci. 2021;36(1):233\u20136.","journal-title":"Lasers Med Sci"},{"issue":"5","key":"707_CR64","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/DSS.0000000000002901","volume":"47","author":"NF Agamia","year":"2021","unstructured":"Agamia NF, Sobhy N, Abd-Elraouf A, Tawfik A. Fractional CO2 laser for transcutaneous drug delivery of onabotulinum toxin in palmar hyperhidrosis. Dermatol Surg. 2021;47(5):678\u201383.","journal-title":"Dermatol Surg"},{"issue":"5","key":"707_CR65","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/bjd.16781","volume":"179","author":"MC Issa","year":"2018","unstructured":"Issa MC, Torre\u00e3o PS, Boechat M, Luiz R. Early investigations in drug delivery of onabotulinum toxin A using combined fractional ablative laser with impact ultrasound vs. injections of onabotulinum toxin A for palmar hyperhidrosis: a right-left comparison trial. Br J Dermatol. 2018;179(5):1168\u20139.","journal-title":"Br J Dermatol"},{"issue":"6","key":"707_CR66","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jvs.2011.12.039","volume":"55","author":"N Wolosker","year":"2012","unstructured":"Wolosker N, de Campos JRM, Kauffman P, Puech-Le\u00e3o P. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg. 2012;55(6):1696\u2013700.","journal-title":"J Vasc Surg"},{"issue":"5","key":"707_CR67","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/bjd.13973","volume":"173","author":"M Schollhammer","year":"2015","unstructured":"Schollhammer M, Brenaut E, Menard-Andivot N, Pillette-Delarue M, Zagnoli A, Chassain-Le Lay M, et al. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial. Br J Dermatol. 2015;173(5):1163\u20138.","journal-title":"Br J Dermatol"},{"issue":"1","key":"707_CR68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/pde.12142","volume":"31","author":"N Wolosker","year":"2014","unstructured":"Wolosker N, Schvartsman C, Krutman M, Campbell TP, Kauffman P, de Campos JR, et al. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old. Pediatr Dermatol. 2014;31(1):48\u201353.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"707_CR69","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10286-014-0264-8","volume":"24","author":"N Wolosker","year":"2014","unstructured":"Wolosker N, Teivelis MP, Krutman M, de Paula RP, de Campos JR, Kauffman P, et al. Long-term results of oxybutynin treatment for palmar hyperhidrosis. Clin Auton Res. 2014;24(6):297\u2013303.","journal-title":"Clin Auton Res"},{"issue":"5","key":"707_CR70","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.avsg.2013.12.024","volume":"28","author":"N Wolosker","year":"2014","unstructured":"Wolosker N, Teivelis MP, Krutman M, de Paula RP, Kauffman P, de Campos JR, et al. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis. Ann Vasc Surg. 2014;28(5):1106\u201312.","journal-title":"Ann Vasc Surg"},{"issue":"10","key":"707_CR71","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1468-3083.2012.04708.x","volume":"27","author":"C M\u00fcller","year":"2013","unstructured":"M\u00fcller C, Berensmeier A, Hamm H, Dirschka T, Reich K, Fischer T, et al. Efficacy and safety of methantheline bromide (Vagantin(\u00ae) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol. 2013;27(10):1278\u201384.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"707_CR72","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/lsm.23073","volume":"51","author":"C Kaminaka","year":"2019","unstructured":"Kaminaka C, Mikita N, Inaba Y, Kunimoto K, Okuhira H, Jinnin M, et al. Clinical and histological evaluation of a single high energy microwave treatment for primary axillary hyperhidrosis in Asians: a prospective, randomized, controlled, split-area comparative trial. Lasers Surg Med. 2019;51(7):592\u20139.","journal-title":"Lasers Surg Med"},{"issue":"5","key":"707_CR73","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10103-020-02958-8","volume":"35","author":"P Rummaneethorn","year":"2020","unstructured":"Rummaneethorn P, Chalermchai T. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis. Lasers Med Sci. 2020;35(5):1179\u201384.","journal-title":"Lasers Med Sci"},{"issue":"4","key":"707_CR74","doi-asserted-by":"publisher","first-page":"adv00435","DOI":"10.2340\/00015555-3790","volume":"101","author":"MAS Henning","year":"2021","unstructured":"Henning MAS, Ibler KS, Loft I, Ullum H, Erikstrup C, Nielsen KR, et al. Epidemiology of hyperhidrosis in danish blood donors. Acta Derm Venereol. 2021;101(4):adv00435.","journal-title":"Acta Derm Venereol"},{"key":"707_CR75","unstructured":"Henning M, Ibler K, Loft I, Jennum P, Didriksen M, Ullum H, et al. Hyperhidrosis is associated with sleep disturbances, daytime tiredness, stress, and depression: a retrospective cohort study from the Danish Blood Donor Study. J Am Acad Dermatol."},{"issue":"11","key":"707_CR76","first-page":"729","volume":"97","author":"JR McConaghy","year":"2018","unstructured":"McConaghy JR, Fosselman D. Hyperhidrosis: management options. Am Fam Physician. 2018;97(11):729\u201334.","journal-title":"Am Fam Physician"},{"issue":"3","key":"707_CR77","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000004172","volume":"10","author":"MJ Solish","year":"2022","unstructured":"Solish MJ, Savinova I, Weinberg MJ. A practical approach to the diagnosis and treatment of palmar hyperhidrosis. Plast Reconstr Surg Glob Open. 2022;10(3): e4172.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"4","key":"707_CR78","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s41649-020-00145-z","volume":"12","author":"K Ooi","year":"2020","unstructured":"Ooi K. The pitfalls of overtreatment: why more care is not necessarily beneficial. Asian Bioeth Rev. 2020;12(4):399\u2013417.","journal-title":"Asian Bioeth Rev"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00707-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-022-00707-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00707-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:45:00Z","timestamp":1700786700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-022-00707-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["707"],"URL":"https:\/\/doi.org\/10.1007\/s40257-022-00707-x","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"assertion":[{"value":"31 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mattias A.S. Henning was provided a grant for research from the LEO Foundation Denmark, grant number LF-18002.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mattias A.S. Henning was provided a grant for research from the LEO Foundation Denmark, grant number LF-18002. Dorra Bouazzi declares that she has no conflict of interest. Gregor B.E. Jemec reports grants and personal fees from AbbVie, personal fees from Coloplast, personal fees from Chemocentryx, personal fees from LEO pharma, grants from LEO Foundation, grants from Afyx, personal fees from Incyte, grants and personal fees from InflaRx, grants from Janssen-Cilag, grants and personal fees from Novartis, grants and personal fees from UCB, grants from CSL Behring, grants from Regeneron, grants from Sanofi, personal fees from Kymera, personal fees from VielaBio, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Ethics approval is not required as this is a literature review.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was not obtained as this is a literature review of already published studies.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Mattias A.S. Henning, Dorra Bouazzi and Gregor B.E. Jemec. The first draft of the manuscript was written by Mattias A.S. Henning and all authors commented on previous versions of the manuscript. All authors read and approved the final article.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}